Latest Partnerships News

Associate Global Partners Limited (AGP) reported its strongest quarterly net inflows since 2017, driving funds under management to $1.72 billion amid successful capital raising and robust investment performance.

Hudson Investment Group signals potential corporate restructure as it explores sale and joint venture options for key Queensland and NSW properties.

NeuRizer Ltd has resolved key regulatory delays for its NeuRizer Urea Project, significantly cut operating costs, and is forging international partnerships to expand its In Situ Gasification technology.

Wrkr Ltd reports strong commercial progress and strategic hires in Q2 FY25, positioning itself for growth with key platform enhancements and pilot completions ahead of Payday Super implementation.

Quantum Graphite has lodged its final US$300 million financing application with the US EXIM Bank for Project Utile, alongside securing a new exploration license EL7019 in South Australia. The company is poised to release updated JORC 2012 exploration targets soon, underpinning its growth strategy.

Critical Minerals Group (CMG) has secured a $2.7 million federal grant to fast-track its vanadium electrolyte manufacturing facility in Queensland, alongside key project milestones and strategic leadership appointments.

Starpharma reports encouraging FDA feedback on its DEP® SN38 candidate for ovarian cancer and prepares for product launches in Saudi Arabia and UAE, supported by a solid $20.3 million cash position.

Austral Resources Australia Ltd reports steady operational progress and promising resource developments in its December 2024 quarter, while navigating an ongoing recapitalisation and leadership transition.

NoviqTech has entered a strategic partnership with Evercity to integrate their platforms and expand blockchain-enabled carbon market solutions, targeting emerging markets like East Africa.

ReNerve Limited has reported a remarkable 260% increase in quarterly sales following its successful IPO, alongside strategic distribution deals in Hong Kong and the Middle East. The company is poised for further growth with upcoming clinical data and product developments.

PhosCo has achieved critical milestones with the approval of its Gassaat Phosphate Project and a strategic MoU with the Tunisian Government and EBRD, setting the stage for a major drilling campaign and positioning itself as a future global fertilizer supplier.

Artrya Limited reports solid progress on its FDA 510(k) application and secures a A$5 million capital raise, positioning itself for imminent commercial rollout in the US healthcare sector.